- Home
- HROW vs TDOC Comparison
HROW vs TDOC Comparison
Compare HROW & TDOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HROW
- TDOC
- Stock Information
- Founded
- HROW 1998
- TDOC 2002
- Country
- HROW United States
- TDOC United States
- Employees
- HROW N/A
- TDOC N/A
- Industry
- HROW Biotechnology: Pharmaceutical Preparations
- TDOC Medical/Nursing Services
- Sector
- HROW Health Care
- TDOC Health Care
- Exchange
- HROW Nasdaq
- TDOC Nasdaq
- Market Cap
- HROW 1.4B
- TDOC 1.4B
- IPO Year
- HROW N/A
- TDOC 2015
- Fundamental
- Price
- HROW $45.09
- TDOC $8.32
- Analyst Decision
- HROW Strong Buy
- TDOC Buy
- Analyst Count
- HROW 7
- TDOC 17
- Target Price
- HROW $64.67
- TDOC $9.80
- AVG Volume (30 Days)
- HROW 506.9K
- TDOC 4.3M
- Earning Date
- HROW 11-12-2025
- TDOC 10-29-2025
- Dividend Yield
- HROW N/A
- TDOC N/A
- EPS Growth
- HROW N/A
- TDOC N/A
- EPS
- HROW N/A
- TDOC N/A
- Revenue
- HROW $227,661,000.00
- TDOC $2,542,268,000.00
- Revenue This Year
- HROW $45.86
- TDOC $0.09
- Revenue Next Year
- HROW $41.41
- TDOC $1.09
- P/E Ratio
- HROW N/A
- TDOC N/A
- Revenue Growth
- HROW 47.69
- TDOC N/A
- 52 Week Low
- HROW $20.85
- TDOC $6.35
- 52 Week High
- HROW $59.23
- TDOC $15.21
- Technical
- Relative Strength Index (RSI)
- HROW 74.17
- TDOC 63.65
- Support Level
- HROW $42.23
- TDOC $7.47
- Resistance Level
- HROW $44.07
- TDOC $7.85
- Average True Range (ATR)
- HROW 1.76
- TDOC 0.27
- MACD
- HROW 0.52
- TDOC 0.04
- Stochastic Oscillator
- HROW 98.28
- TDOC 89.44
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
About TDOC Teladoc Health Inc.
Teladoc Health Inc is engaged in virtual care, forging a new healthcare experience with improved convenience, outcomes, and value. Its mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems.